CC
APGN

Centiva Capital’s Apexigen, Inc. Common Stock APGN Stock Holding History

Centiva Capital’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,140
Closed -$122K – 2075
2022
Q1 		$122K Buy
+12,140
New +$122K ﹤0.01% 1364

Other funds holding APGN

MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return

Centiva Capital's APGN Position: Q2 2022 in Review

Centiva Capital sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2022, closing a stake of 12,140 shares — an estimated $122K sold.

Centiva Capital first reported a position in APGN in Q1 2022 and held it in 1 quarter. The position peaked at $122K in Q1 2022. 27 funds tracked by Wall St. Rank hold APGN as of Q2 2022.

  • Centiva Capital reported no remaining Apexigen, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Centiva Capital sold 12,140 Apexigen, Inc. Common Stock shares in Q2 2022, an estimated $122K.
  • Centiva Capital first reported a position in Apexigen, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Centiva Capital's Apexigen, Inc. Common Stock position peaked at $122K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2022.

Based on Centiva Capital's 13F filing for Q2 2022, filed 15 Aug 2022.